Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Company Announcement
COPENHAGEN, Denmark; February 23, 2024 – Genmab A/S (Nasdaq: GMAB) - In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document discloses the data of the transactions made in Genmab A/S (Nasdaq: GMAB) by managerial employees and their closely associated persons.
The company’s managerial employees and their closely associated persons have given Genmab A/S power of attorney on their behalf to publish trading in Genmab shares by the company’s managerial employees and their closely associated persons.
Please find below a statement of such trading in shares issued by Genmab A/S
1. | Details of the person discharging managerial responsibilities / person closely associated | ||
a) | Name | Jan G. J. van de Winkel | |
2. | Reason for the notification | ||
a) | Position/status | President & Chief Executive Officer | |
b) | Initial notification/Amendment | Initial notification | |
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Genmab A/S | |
b) | LEI-code | 529900MTJPDPE4MHJ122 | |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument Identification code | Restricted Stock Units related to shares of Genmab A/S DK0010272202 | |
b) | Nature of the transaction | Grant of Restricted Stock Units | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
DKK 0.00 | 27,404 (annual equity award) | ||
DKK 0.00 | 1,004 (deferred annual cash bonus) | ||
d) | Aggregated information - Aggregated volume - Price | 28,408 DKK 0.00 | |
e) | Date of the transaction | 2024-02-23 | |
f) | Place of the transaction | Outside the market |
1. | Details of the person discharging managerial responsibilities / person closely associated | ||
a) | Name | Anthony Pagano | |
2. | Reason for the notification | ||
a) | Position/status | Executive Vice President & Chief Financial Officer | |
b) | Initial notification/Amendment | Initial notification | |
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Genmab A/S | |
b) | LEI-code | 529900MTJPDPE4MHJ122 | |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument Identification code | Restricted Stock Units related to shares of Genmab A/S DK0010272202 | |
b) | Nature of the transaction | Grant of Restricted Stock Units | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
DKK 0.00 | 13,043 (annual equity award) | ||
DKK 0.00 | 286 (deferred annual cash bonus) | ||
d) | Aggregated information - Aggregated volume - Price | 13,329 DKK 0.00 | |
e) | Date of the transaction | 2024-02-23 | |
f) | Place of the transaction | Outside the market |
1. | Details of the person discharging managerial responsibilities / person closely associated | ||
a) | Name | Martin Schultz | |
2. | Reason for the notification | ||
a) | Position/status | Member of the Board of Directors | |
b) | Initial notification/Amendment | Initial notification | |
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Genmab A/S | |
b) | LEI-code | 529900MTJPDPE4MHJ122 | |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument Identification code | Restricted Stock Units related to shares of Genmab A/S DK0010272202 | |
b) | Nature of the transaction | Grant of Restricted Stock Units (as employee of Genmab A/S, not as board member) | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
DKK 0.00 | 270 | ||
d) | Aggregated information - Aggregated volume - Price | ||
e) | Date of the transaction | 2024-02-23 | |
f) | Place of the transaction | Outside the market |
1. | Details of the person discharging managerial responsibilities / person closely associated | ||
a) | Name | Takahiro Hamatani | |
2. | Reason for the notification | ||
a) | Position/status | Member of the Board of Directors | |
b) | Initial notification/Amendment | Initial notification | |
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Genmab A/S | |
b) | LEI-code | 529900MTJPDPE4MHJ122 | |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument Identification code | Restricted Stock Units related to shares of Genmab A/S DK0010272202 | |
b) | Nature of the transaction | Grant of Restricted Stock Units (as employee of Genmab K.K., not as board member) | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
DKK 0.00 | 148 | ||
d) | Aggregated information - Aggregated volume - Price | ||
e) | Date of the transaction | 2024-02-23 | |
f) | Place of the transaction | Outside the market |
1. | Details of the person discharging managerial responsibilities / person closely associated | ||
a) | Name | Mijke Zachariasse | |
2. | Reason for the notification | ||
a) | Position/status | Member of the Board of Directors | |
b) | Initial notification/Amendment | Initial notification | |
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Genmab A/S | |
b) | LEI-code | 529900MTJPDPE4MHJ122 | |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument Identification code | Restricted Stock Units related to shares of Genmab A/S DK0010272202 | |
b) | Nature of the transaction | Grant of Restricted Stock Units (as employee of Genmab B.V., not as board member) | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
DKK 0.00 | 258 | ||
d) | Aggregated information - Aggregated volume - Price | ||
e) | Date of the transaction | 2024-02-23 | |
f) | Place of the transaction | Outside the market |
1. | Details of the person discharging managerial responsibilities / person closely associated | ||
a) | Name | Martin Schultz | |
2. | Reason for the notification | ||
a) | Position/status | Member of the Board of Directors | |
b) | Initial notification/Amendment | Initial notification | |
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Genmab A/S | |
b) | LEI-code | N/A | |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument Identification code | Warrants related to shares of Genmab A/S DK0010272202 | |
b) | Nature of the transaction | Gran
By: GlobeNewswire
- 23 Feb 2024
Return to news
Upcoming Life Sciences Events
Latest company newsThere are currently no news available for this portal |